Noticias de VIR_US

Noticias del mercado

Últimas noticias sobre VIR_US — 183 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: VIR_US ✕ 183 resultados
22/04/2026 VIR_US — Insider Monkey ES ← EN
Vir Biotechnology (VIR) registra un crecimiento del 80,98% en lo que va del año
22/04/2026 VIR_US — Insider Monkey
Vir Biotechnology (VIR) Posts 80.98% Year-To-Date Growth
22/04/2026 VIR_US — Yahoo Finance
Vir Biotechnology (VIR) Posts 80.98% Year-To-Date Growth
21/04/2026 VIR_US — HarianBasis.co ES ← EN
Vir Biotechnology administra dosis al primer paciente en un ensayo clínico sobre cáncer de próstata

Vir Biotechnology Doses First Patient in Prostate Cancer Clinical Trial

20/04/2026 VIR_US — Investing.com ES ← EN
Las acciones de Vir Biotechnology alcanzan su máximo de 52 semanas a 10,94 dólares Por Investing.com

Vir Biotechnology stock hits 52-week high at $10.94 By Investing.com

20/04/2026 VIR_US — Investing.com ES ← EN
Las acciones de Vir Biotechnology alcanzan su máximo de 52 semanas a 10,94 dólares Por Investing.com

Vir Biotechnology stock hits 52-week high at $10.94 By Investing.com

20/04/2026 VIR_US — Investing.com
Vir Biotechnology stock hits 52-week high at $10.94 By Investing.com
20/04/2026 VIR_US — Investing.com
Vir Biotechnology stock hits 52-week high at $10.94
20/04/2026 VIR_US — MarketBeat
Vir Biotechnology (NASDAQ:VIR) Sets New 1-Year High - Here's Why
20/04/2026 VIR_US — Yahoo Finance
Can Vir Biotechnology (VIR)’s Masked T-Cell Technology Crack the Hardest-to-Treat Prostate Cancer?
19/04/2026 VIR_US — Insider Monkey ES ← EN
¿Es Vir Biotechnology (VIR) una de las acciones de biotecnología con mejores precios económicos para invertir?
19/04/2026 VIR_US — Yahoo Finance
Is Vir Biotechnology (VIR) One of the Best Low Priced Biotech Stocks to Invest In?
17/04/2026 VIR_US — DirectorsTalk Interviews
Vir Biotechnology, Inc. (VIR) Stock Analysis: Exploring a Potential 101% Upside in the Biotech Sector
16/04/2026 VIR_US — Investing.com
Vir Biotechnology closes $240M Astellas deal for cancer drug By Investing.com
16/04/2026 VIR_US — Stock Titan
A $240M cash infusion backs Vir-Astellas prostate cancer push
16/04/2026 VIR_US — Quiver Quantitative
Vir Biotechnology, Inc. ($VIR) CEO 2025 Pay Revealed
16/04/2026 VIR_US — Business Wire
Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatment of Prostate Cancer
16/04/2026 VIR_US — MarketScreener
Vir Biotechnology, Inc. Receives $240 Million Upfront Payment and $75 Million Equity Investment from Astellas
16/04/2026 VIR_US — Stock Titan
Vir Biotechnology (NASDAQ: VIR) sets 2026 meeting and pay vote
16/04/2026 VIR_US — Investing.com
Vir Biotechnology closes $240M Astellas deal for cancer drug

Página 4 de 10

keyboard_arrow_up